McKinsey advised drugmaker Purdue on how to ‘turbocharge’ sales of highly addictive products
PUBLISHED : 13 Dec 2024 at 22: 01
(Reuters File Photo)
BOSTON – The multinational consulting firm McKinsey & Co has agreed to pay $650 million to resolve a US criminal investigation into its work advising the opioid manufacturer Purdue Pharma on how to boost sales.
McKinsey has entered into a five-year deferred prosecution agreement filed in federal court to resolve criminal charges brought as part of
Read More